Research Interest:
Dr Buntzman’s research leverages transcriptomics, high throughput computational immunogenomics, and genetics methodologies to reveal the adaptive immune response characteristics that are central to the pathogenesis of coccidioidomycosis infections and the protective immunity generated by vaccination. Dr Buntzman’s global goals are to improve diagnostic testing and to develop novel therapeutics modalities for patients with coccidioidomycosis.